Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate
- 1 October 1992
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (9) , 879-885
- https://doi.org/10.1016/0002-9149(92)90731-d
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardiaAmerican Heart Journal, 1990
- Effect of intravenous magnesium sulfate on supraventricular tachycardiaThe American Journal of Cardiology, 1989
- Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.Circulation, 1988
- Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac diseaseAmerican Heart Journal, 1988
- Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patient?American Heart Journal, 1987
- Effects of magnesium sulfate on cardiac conduction and refractoriness in humansJournal of the American College of Cardiology, 1986
- Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: Clinical and experimental aspectsJournal of the American College of Cardiology, 1984
- Magnesium: Nature's physiologic calcium blockerAmerican Heart Journal, 1984
- Electrophysiologic effects of adenosine-5'-triphosphate on atrioventricular reentrant tachycardia.Circulation, 1983
- Dipyridamole inhibition of adenosine metabolism in human bloodEuropean Journal of Pharmacology, 1983